Evolution of Insulin Patents and Market Exclusivities in the USA

Lancet Diabetes Endocrinol. 2015 Nov;3(11):835-7. doi: 10.1016/S2213-8587(15)00364-2. Epub 2015 Oct 6.

MeSH terms

  • Diabetes Mellitus / drug therapy
  • Drug Design
  • Drugs, Generic / economics*
  • Humans
  • Hypoglycemic Agents / economics*
  • Hypoglycemic Agents / therapeutic use
  • Insulin / economics*
  • Insulin / therapeutic use
  • Patents as Topic
  • United States

Substances

  • Drugs, Generic
  • Hypoglycemic Agents
  • Insulin